Cite
HARVARD Citation
Cotton, S. et al. (2017). Targeted O‐glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced‐stage bladder tumours. Molecular oncology. 11 (8), pp. 895-912. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cotton, S. et al. (2017). Targeted O‐glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced‐stage bladder tumours. Molecular oncology. 11 (8), pp. 895-912. [Online].